Clinical Trial Update: Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT [NA]

View source ↗

Summary

The HABIT trial evaluating hydroxyurea adherence in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Columbia University | Conditions: Sickle Cell Disease | NA | Status: COMPLETED